{"title":"Pilot-scale co-precipitation synthesis of a novel active ingredient made of ultrasmall iron (oxyhydr)oxide nanoparticles for the treatment of hyperphosphatemia","link":"http://pubs.rsc.org/en/Content/ArticleLanding/2024/RA/D4RA02719A","date":null,"content":"<div><p><img src=\"/services/images/RSCpubs.ePlatform.Service.FreeContent.ImageService.svc/ImageService/image/GA?id=D4RA02719A\" /></p></div><div><i><b>RSC Adv.</b></i>, 2024, <b>14</b>,16117-16127<br /><b>DOI</b>: 10.1039/D4RA02719A, Paper</div><div><img alt=\"Open Access\" src=\"http://sod-a.rsc-cdn.org/pubs.rsc-uat.org/content/NewImages/open_access_blue.png\" /> Open Access</div><div><a href=\"http://creativecommons.org/licenses/by/3.0/\" target=\"_blank\"> <img src=\"http://sod-a.rsc-cdn.org/pubs.rsc-uat.org/content/NewImages/CCBY.png\" alt=\"Creative Commons Licence\" /></a>  This article is licensed under a <a href=\"http://creativecommons.org/licenses/by/3.0/\" target=\"_blank\">Creative Commons Attribution 3.0 Unported Licence.</a></div><div>Magdalena Teresa Spicher, Sebastian Patrick Schwaminger, Daniela von der Haar-Leistl, Marian Montiel Peralta, Georgina Mikacevic, Friedrich Ernst Wagner, Sonja Berensmeier<br />Ultrasmall iron (oxyhydr)oxide nanoparticles can be prepared with a yield &gt;40 g L<small><sup>−1</sup></small> on a pilot scale by co-precipitation without losing their exceptionally high phosphate-binding efficacy. Only slight changes in composition were observed, attributed to a reduction in core size.<br />The content of this RSS Feed (c) The Royal Society of Chemistry</div>","author":"","siteTitle":"RSC - RSC Adv. latest articles","siteHash":"da3e282678330308414c63a405ade89dd3738fcce2936ca8a2fe3a6d7e967d99","entryHash":"2b49f19f9bfe2c7533e0154de5d295dc89d28648548bc4903caa7e89d1aa0f34","category":"Environment"}